Intellectual property • United States

Baker McKenzie LLP
bakermckenzie.comLawyers
Jessica Greenwald
Baker McKenzie LLP, United States
- Phone+1 214 978 3063
- Email[email protected]
- Profilewww.bakermckenzie.com
Work Department
Intellectual Property and Technology Law
Position
Jessie’s practice includes intellectual property (IP) support in business transactions, coordination of global patent assignments and recordals, global patent portfolio strategy and management, and patent prosecution. Prior to entering law school, she earned her doctorate in Plant Pathology and Microbiology focusing on iron regulatory networks of bacterial pathogens. This technical background has lent nicely to her focus on patent matters, especially those pertaining to life sciences and biotechnology.
Career
Developed and managed the global filing and prosecution strategy for a technology start-up company focused on the sustainable production and extraction of plant based protein, including providing strategic filing advice based on their key markets, competitors, and enforcement limitations.
Developed and managed global prosecution strategy for a major Texas University in the genetically modified crop space.
Manage the global plant variety rights and patent filings and prosecution thereof for the global leader in kiwi production and distribution.
Advised international pharmaceutical company regarding the IP aspects of a $1.95 billion public company acquisition of a clinical stage biopharmaceutical company focused on the development of migraine therapies. Jessie's contributions to the deal focused heavily on the analysis of the target company's patent portfolio and IP related agreements.
Advised a Japanese technology company regarding IP aspects of a $1 billion acquisition of a genetic diagnostics company, and thus contributing to their goal of developing a precision medicine platform.
Advised an Australian-based regenerative medicine company in connection with a proposed US public share offering.
Provided patentability and non-infringement advice to a blood products manufacturer relating to IVIG and fibrinogen related technologies.
Languages
English
Memberships
Dallas Association of Young Lawyers
Dallas Bar Association
Mentions
Content supplied by Baker McKenzie LLP